Portal de Periódicos da CAPES

Ghrelin treatment protects lactotrophs from apoptosis in the pituitary of diabetic rats

2009; Elsevier BV; Volume: 309; Issue: 1-2 Linguagem: Inglês

10.1016/j.mce.2009.06.006

1872-8057

Miriam Granado, Julie A. Chowen, Cristina García‐Cáceres, Arancha Delgado‐Rubín de Célix, Vicente Barrios, Estíbaliz Castillero, Jesús Argente, Laura M. Frago,

Adipose Tissue and Metabolism

Poorly controlled diabetes is associated with hormonal imbalances, including decreased prolactin production partially due to increased lactotroph apoptosis. In addition to its metabolic actions, ghrelin inhibits apoptosis in several cell types. Thus, we analyzed ghrelin's effects on diabetes-induced pituitary cell death and hormonal changes. Six weeks after onset of diabetes in male Wistar rats (streptozotocin 70 mg/kg), minipumps infusing saline or 24 nmol ghrelin/day were implanted (jugular). Rats were killed two weeks later. Ghrelin did not modify body weight or serum glucose, leptin or adiponectin, but increased total ghrelin (P < 0.05), IGF-I (P < 0.01) and prolactin (P < 0.01) levels. Ghrelin decreased cell death, iNOS and active caspase-8 (P < 0.05) and increased prolactin (P < 0.05), Bcl-2 (P < 0.01) and Hsp70 (P < 0.05) content in the pituitary. In conclusion, ghrelin prevents diabetes-induced death of lactotrophs, decreasing caspase-8 activation and iNOS content and increasing anti-apoptotic pathways such as pituitary Bcl-2 and Hsp70 and serum IGF-I concentrations.